よむ、つかう、まなぶ。
05資料2-1森野委員提出資料（RSウイルス母子免疫ワクチンと抗体製剤ファクトシート） (43 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_64997.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会（第32回 10／22）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
3. 引用文献
1.
Welliver RC, Hall CB. Respiratory Syncytial Virus. In: Cherry JD, Harrison GJ, Kaplan SL,
Steinbach WJ, Hotez PJ, eds. Feigin & Cherry's Textbook of Pediatric Infectious Diseases. 8 ed.
Philadelphia: ELSEVIER; 2019: 1780-97.
2.
Colosia A, Costello J, McQuarrie K, Kato K, Bertzos K. Systematic literature review of the signs
and symptoms of respiratory syncytial virus. Influenza Other Respir Viruses 2023; 17(2): e13100.
3.
Miron V, Raianu RO, Filimon C, Craiu MA. Clinical Differences between SARS-CoV-2 and RSV
Infections in Infants: Findings from a Case-Control Study. Viruses 2023; 16(1): 63.
4.
Lebreiro GP, Venceslau MT, Guimarães M, et al. Respiratory syncytial virus infection in
children during SARS-CoV-2 pandemic at a referral center in Rio de Janeiro, Brazil. J Bras Pneumol
2024; 50(3): e20240072.
5.
Nagasawa K, Ohata M, Igarashi A, et al. Prospective hospital-based cohort studies of
Respiratory Syncytial Virus (RSV) infections in infants under one year during and after the SARS-CoV-2
pandemic in Japan. Int J Infect Dis 2024; 149: 107252.
6.
Walsh ED, Englund JA. Respiratory Syncytial Virus. In: Bennett JE, Dolin R, Blaser MJ, eds.
Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9 ed. Philadelphia:
ELSEVIER; 2020: 2093–103.
7.
Nagasawa K, Ishiwada N. Disease burden of respiratory syncytial virus infection in the
pediatric population in Japan. J Infect Chemother 2022; 28(2): 146-57.
8.
Kawasaki Y, Suyama K, Go H, Hosoya M. Clinical manifestations of respiratory syncytial virus-
associated encephalopathy in Fukushima, Japan. Pediatr Int 2019; 61(8): 802-6.
9.
Takeuchi S, Kawada JI, Okuno Y, et al. Identification of potential pathogenic viruses in patients
with acute myocarditis using next-generation sequencing. J Med Virol 2018; 90(12): 1814-21.
10.
Custovic A, Mestre-Ferrandiz J, Kragten-Tabatabaie L, et al. Parent's perception of respiratory
syncytial virus and subsequent wheezing burden: A multi-country cross-sectional survey. Pediatr Allergy
Immunol 2024; 35(6): e14169.
11.
Hall CB. Respiratory syncytial virus: its transmission in the hospital environment. Yale J Biol
Med 1982; 55(3-4): 219-23.
12.
Sasaki H, Seoka R, Yagi M, Komano J. The Role of Human Mobility Flow in the Region-to-
Region Spread of Respiratory Syncytial Virus Infection among Infants: An Infographic Analysis. Biol
Pharm Bull 2024; 47(5): 924-9.
13.
Kombe IK, Agoti CN, Munywoki PK, Baguelin M, Nokes DJ, Medley GF. Integrating
epidemiological and genetic data with different sampling intensities into a dynamic model of respiratory
syncytial virus transmission. Sci Rep 2021; 11(1): 1463.
14.
Otomaru H, Sornillo JBT, Kamigaki T, et al. Risk of Transmission and Viral Shedding From the
Time of Infection for Respiratory Syncytial Virus in Households. Am J Epidemiol 2021; 190(12): 2536-43.
15.
Walter EB, Munoz FM. New Approaches to Respiratory Syncytial Virus Prevention and
Treatment. Annu Rev Med 2025; 76(1): 13-28.
43
1.
Welliver RC, Hall CB. Respiratory Syncytial Virus. In: Cherry JD, Harrison GJ, Kaplan SL,
Steinbach WJ, Hotez PJ, eds. Feigin & Cherry's Textbook of Pediatric Infectious Diseases. 8 ed.
Philadelphia: ELSEVIER; 2019: 1780-97.
2.
Colosia A, Costello J, McQuarrie K, Kato K, Bertzos K. Systematic literature review of the signs
and symptoms of respiratory syncytial virus. Influenza Other Respir Viruses 2023; 17(2): e13100.
3.
Miron V, Raianu RO, Filimon C, Craiu MA. Clinical Differences between SARS-CoV-2 and RSV
Infections in Infants: Findings from a Case-Control Study. Viruses 2023; 16(1): 63.
4.
Lebreiro GP, Venceslau MT, Guimarães M, et al. Respiratory syncytial virus infection in
children during SARS-CoV-2 pandemic at a referral center in Rio de Janeiro, Brazil. J Bras Pneumol
2024; 50(3): e20240072.
5.
Nagasawa K, Ohata M, Igarashi A, et al. Prospective hospital-based cohort studies of
Respiratory Syncytial Virus (RSV) infections in infants under one year during and after the SARS-CoV-2
pandemic in Japan. Int J Infect Dis 2024; 149: 107252.
6.
Walsh ED, Englund JA. Respiratory Syncytial Virus. In: Bennett JE, Dolin R, Blaser MJ, eds.
Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9 ed. Philadelphia:
ELSEVIER; 2020: 2093–103.
7.
Nagasawa K, Ishiwada N. Disease burden of respiratory syncytial virus infection in the
pediatric population in Japan. J Infect Chemother 2022; 28(2): 146-57.
8.
Kawasaki Y, Suyama K, Go H, Hosoya M. Clinical manifestations of respiratory syncytial virus-
associated encephalopathy in Fukushima, Japan. Pediatr Int 2019; 61(8): 802-6.
9.
Takeuchi S, Kawada JI, Okuno Y, et al. Identification of potential pathogenic viruses in patients
with acute myocarditis using next-generation sequencing. J Med Virol 2018; 90(12): 1814-21.
10.
Custovic A, Mestre-Ferrandiz J, Kragten-Tabatabaie L, et al. Parent's perception of respiratory
syncytial virus and subsequent wheezing burden: A multi-country cross-sectional survey. Pediatr Allergy
Immunol 2024; 35(6): e14169.
11.
Hall CB. Respiratory syncytial virus: its transmission in the hospital environment. Yale J Biol
Med 1982; 55(3-4): 219-23.
12.
Sasaki H, Seoka R, Yagi M, Komano J. The Role of Human Mobility Flow in the Region-to-
Region Spread of Respiratory Syncytial Virus Infection among Infants: An Infographic Analysis. Biol
Pharm Bull 2024; 47(5): 924-9.
13.
Kombe IK, Agoti CN, Munywoki PK, Baguelin M, Nokes DJ, Medley GF. Integrating
epidemiological and genetic data with different sampling intensities into a dynamic model of respiratory
syncytial virus transmission. Sci Rep 2021; 11(1): 1463.
14.
Otomaru H, Sornillo JBT, Kamigaki T, et al. Risk of Transmission and Viral Shedding From the
Time of Infection for Respiratory Syncytial Virus in Households. Am J Epidemiol 2021; 190(12): 2536-43.
15.
Walter EB, Munoz FM. New Approaches to Respiratory Syncytial Virus Prevention and
Treatment. Annu Rev Med 2025; 76(1): 13-28.
43